Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis

• Main Authors: Lin Li (Author), Jinghao Li (Author), Qilong Wang (Author), Xin Zhao (Author), Dongli Yang (Author), Lu Niu (Author), Yanze Yang (Author), Xianxian Zheng (Author), Limin Hu (Author), Yuhong Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Shenmai injection (SMI), as a patented traditional Chinese medicine, is extracted from Panax ginseng and Ophiopogon japonicus. It commonly used in the treatment of cardiovascular disease and in the control of cardiac toxicity induced by doxorubicin (DOX) treatment. However, its anti-cardiotoxicity m...